Hemato Oncology Testing Market Share, Development and Demand Forecast to 2030

In 2022, the hemato oncology testing market was worth around USD 2,812.7 million, and it is predicted to advance at a 15.0% CAGR from 2022 to 2030, hitting USD 8,594.0 million in 2030.

The regular occurrence of numerous kinds of hematological malignancies, ongoing research on the same, extraordinary progresses in therapeutic and diagnostic technologies, and rising knowledge on such conditions result in a positive impact on the market.

Hematological malignancy occurrence has significantly hiked in the past few years. There are a great number of people who are either suffering from leukemia or multiple myeloma, or lymphoma or are in remission.

As per the Epidemiology, Surveillance, and End Results Program, 3.8% of all cancer demises in 2020 were because of leukemia. The major reason behind the growth in cancer incidence is the growing elderly population. The elder generation is more vulnerable to chronic diseases and possibly grows this disease. According to WHO between 2010 and 2021, the share of individuals aged 65 in the universal populace gained from 8% to 10%.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hemato-oncology-testing-market

North America led the market, with the largest revenue share of approximately 40%, in 2022. The snowballing occurrence of multiple myeloma, leukemia, and lymphoma especially in the U.S., is mainly accountable for this. Also, a growth in Hodgkin’s lymphoma incidence is projected to promote industry expansion throughout the projection period.

Hence, the regular occurrence of numerous kinds of hematological malignancies, ongoing research on the same, extraordinary progresses in therapeutic and diagnostic technologies, and rising knowledge on such conditions result in a positive impact on the market.

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.